Search

9 May 2022: Hybridoma cell line producing YAML 555.6 antibodies raised against human leukocyte antigen DR (HLA-DR) which are rat monoclonal antibodies of the IgG2a isotype.

9 May 2022: Hybridoma cell line producing 6D5 antibodies rasied against CD19 membrane protein of mouse B lymphocytes which are rat monoclonal antibodies of the IgG2a isotype.

9 May 2022: Q3PULSE is software for predicting unsteady turbocharger turbine performance, particularly under pulsating flow conditions.

9 May 2022: Hybridoma cell line producing CB4 antibodies raised against Herpes Simplex Virus Type-1 protein pUL36 (VP1/2), mouse monoclonals of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing AP7 antibodies against Herpes Simplex Virus Type-1 and Type-2 envelope protein Glycoprotein D, which are of the IgG2a isotype.

9 May 2022: Hybridoma cell line producing LP11 antibodies raised against Herpes Simplex Virus Type-1 envelope protein Glycoprotein H, which are of the IgG2a isotype.

9 May 2022: Hybridoma cell line producing AP12 antibodies against Herpes Simplex Virus Type-1 and Type-2 envelope protein Glycoprotein D, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing LP14 antibodies against Herpes Simplex Virus Type-1 and Type-2 envelope protein Glycoprotein D which are of the IgG2a isotype.

9 May 2022: KARPAS 299 Human Non-Hodgkin's Ki-positive Large Cell Lymphoma cell line useful in oncology research, developed at the University of Cambridge.

9 May 2022: Hybridoma cell line producing CB24 monoclonal antibodies raised against Herpes Simplex Virus Type-1 envelope protein Glycoprotein B, of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing BBH1 monoclonal antibodies raised against Herpes Simplex Virus Type-1 envelope protein Glycoprotein H, of the IgG2a isotype.

9 May 2022: Hybridoma cell line producing LP13 antibodies raised against Herpes Simplex Virus Type-1 VP21/VP22a scaffold protein, mouse monoclonals of IgG2a isotype.

9 May 2022: Hybridoma cell line producing IGF-1R 1-2 antibodies raised against the extreme C-terminus of the human insulin-like growth factor receptor beta subunit.

9 May 2022: Hybridoma cell line producing IGF-1R 26-3 antibodies against human insulin-like growth factor receptor (epitope 283-440 or 586-908) and of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IGF-1R 24-57 antibodies raised against the human insulin-like growth factor receptor, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IGF-1R 24-31 antibodies against human insulin-like growth factor 1 receptor (283-440 or 586-908 epitope).

9 May 2022: Hybridoma cell line producing IGF-1R 24-60 antibodies against the human insulin-like growth factor receptor (epitope 184-283), which are the IgG2a isotype.

9 May 2022: ICM+ software provides real-time multimodality monitoring, analysis and data storage in neurological intensive care environments.

9 May 2022: Hybridoma cell line producing IGF-1R 24-55 antibodies against the human insulin-like growth factor receptor (epitope 440-586) which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IGF-1R 17-69 antibodies against the human insulin-like growth factor receptor (epitope 440-586) which are of the IgG1 isotype.

9 May 2022: GreenSwirl is a MATLAB programme to calculate the Green's function for swirling flow in an infinite duct.

9 May 2022: Hybridoma cell line producing LP6 antibodies raised against Herpes Simplex Virus Type-2 envelope protein Glycoprotein C, which are of the IgG2a isotype.

9 May 2022: Hybridoma cell line producing AP10 antibodies raised against Herpes Simplex Virus Type-2 envelope protein Glycoprotein E, which are of the IgG2a isotype.

9 May 2022: Hybridoma cell line producing LP10 antibodies raised against Herpes Simplex Virus Type-1 envelope protein Glycoprotein G, which are of the IgG3 isotype.

9 May 2022: Hybridoma cell line producing AP1 antibodies raised against Herpes Simplex Virus Type-2 envelope protein Glycoprotein G, which are of the IgG2a isotype.

9 May 2022: Hybridoma cell line producing LP12 antibodies raised against Herpes Simplex Virus Type-1 and 2 Major Capsid antigen (VP5), which are of the IgG2a isotype.

9 May 2022: Hybridoma cell line producing LP1 antibodies raised against Herpes Simplex Virus Type-1 and Type-2 tegument protein VP16, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing LP2 antibodies raised against Herpes Simplex Virus Type-1 and -2 envelope protein Glycoprotein D, which are the IgG2a isotype.